Abstract
The mathematical study of the growth and treatment of cancer has been of great interest to researchers in the recent past as that can help clinical practitioners in adopting new treatment strategies to fight effectively against cancer. Although chemotherapy is the most common method of cancer treatment, the drug-resistant nature of tumor cells and the toxic effect of chemotherapeutic drugs on normal cells are major threats to the success of chemotherapy. In this paper, we propose a multi-drug chemotherapy model combined with an optimal control approach in which the amount of drugs is taken as control functions. The underlying mathematical model discusses the evolution of a heterogeneous tumor population and the dynamics of normal cells under chemotherapy. The model incorporates the pharmacokinetics of the anticancer agents as well. The proposed optimal control approach ensures maximum decay of the tumor cells while preserving a sufficient level of normal cells that would help faster recovery.
Similar content being viewed by others
References
de Pillis, L.G.: Seeking bang-bang solutions of mixed immuno-chemotherapy of tumors. Electr. J. Differ. Equ. 2017, 1–24 (2007)
de Pillis, L.G., Gu, W., Radunskaya, A.E.: Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations. J. Theor. Biol. 238, 841–62 (2006)
de Pillis, L.G., Radunskaya, A.E.: A mathematical tumor model with immune resistance and drug therapy: an optimal control approach. J. Theor. Med. 3, 79–100 (2001)
Feizabadi, M.S.: Modeling multi-mutation and drug resistance: analysis of some case studies. Theor. Biol. Med. Model. 14, 6 (2017)
Feizabadi, M.S., Witten, T.M.: Chemotherapy in conjoint aging-tumor systems: some simple models for addressing coupled aging-cancer dynamics. Theor. Biol. Med. Model. 7, 21 (2010)
Fister, K.R., Donnelly, J.H.: Immunotherapy: an optimal control theory approach. Math. Biosci. Eng. 2, 499–510 (2005)
Fleming, W.H., Rishel, R.W.: Deterministic and Stochastic Optimal Control. Springer, New York (1975)
Greene, J.M., Gevertz, J.L., Sontag, E.D.: Mathematical approach to differentiate spontaneous and induced evolution to drug resistance during cancer treatment. JCO Clin. Cancer Inform. 3, 1–20 (2019)
Holohan, C., Van Schaeybroeck, S., Longley, D.B., Johnston, P.G.: Cancer drug resistance: an evolving paradigm. Nat. Rev. Cancer 13, 714–726 (2013)
Kamien, M.I., Schwartz, N.L.: Dynamic Optimization: The Calculus of Variations and Optimal Control in Economics and Management, 2nd edn. North-Holland, New York (1998)
Ledzewicz, U., Schattler, H.: A 3-compartment model of heterogeneous tumor populations. Acta. Appl. Math. 135, 191–207 (2014)
Ledzewicz, U., Schattler. H.: Optimal bang-bang control for a two compartment model in cancer chemotherapy. J. Optim. Theory Appl. 114, 609-637 (2002)
Lenhart, S., Workman, J.: Optimal Control Applied to Biological Models. Chapman Hall/CRC, Boca Raton (2007)
Maurer, H.: On optimal control problems with bounded state variables and control appearing linearly. SIAM J. Control Optim. 15, 345–362 (1977)
Maurer, H., do Rosario de Pinho, M.: Optimal control of epidemiological SEIR models with L1-objectives and control-state constraints. Pac. J. Optim. 12, 415-436 (2016)
Namazi, H., Kulish, V., Wong, A.: Mathematical modelling and prediction of the effect of chemotherapy on cancer cells. Sci. Rep. 5, 13583 (2015)
Nanditha, C.K., Rajan, M.P.: An adaptive pharmacokinectic optimal control approach in chemotherapy for hetrogeneous tumor. J. Biol. Syst. (Accepted) (2022)
Piretto, E., Delitala, M., Ferraro, M.: Combination therapies and intra-tumoral competition: insights from mathematical modeling. J. Theor. Biol. 446, 149–159 (2018)
Pluchino, K.M., Hall, M.D., Goldsborough, A.S., Callaghan, R., Gottesman, M.M.: Collateral sensitivity as a strategy against cancer multidrug resistance. Drug Resist. Updat. 15, 98–105 (2012)
Pucci, C., Martinelli, C., Ciofani, G.: Innovative approaches for cancer treatment: current perspectives and new challenges. Ecancermedicalscience 13, 961 (2019)
Rihan, F.A., Lakshmanan, S., Maurer, H.: Optimal control of tumour-immune model with time-delay and immuno-chemotherapy. Appl. Math. Comput. 353, 147–165 (2019)
Rihan, F.A., Rihan, N.F.: Dynamics of cancer-immune system with external treatment and optimal control. J. Cancer Sci. Ther. 8, 257–261 (2016)
Sabir, S., Raissi, N., Serhani, M.: Chemotherapy and immunotherapy for tumors: a study of quadratic optimal control. Int. J. Appl. Comput. Math. 6, 81 (2020)
Sbeity, H., Younes, R.: Review of optimization methods for cancer chemotherapy treatment planning. J. Comput. Sci. Syst. Biol. 8, 074–095 (2015)
Sethi, S.P., Thompson, G.L.: Optimal Control Theory: Applications to Management Science and Economics. Kluwer Academic Publishers (2000)
Takayama, A.: Mathematical Economics. Dryden Press, Hinsdale (1974)
Tomasetti, C., Levy, D.: An elementary approach to modeling drug resistance in cancer. Math. Biosci. Eng. 7, 905–918 (2010)
Acknowledgements
We profoundly thank the unknown referee(s) for their careful reading of the manuscript and valuable suggestions that significantly improved the presentation of the paper as well.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Urszula A. Ledzewicz.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Rajan, M.P., Nanditha, C.K. A Multi-Drug Pharmacokinectic Optimal Control Approach in Cancer Chemotherapy. J Optim Theory Appl 195, 314–333 (2022). https://doi.org/10.1007/s10957-022-02085-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10957-022-02085-0